Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endocrine System Diseases × Octreotide × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 6 Neoplasms 4 Carcinoid Tumor 4 Carcinoma 3 Vipoma 2 Neoplasm Metastasis 2 Intestinal Obstruction 2 Carcinoma, Islet Cell 2 Somatostatinoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Inoperable Thymoma 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Malignant Carcinoid Syndrome 1 Lymphangiomyoma 1 Lymphangioleiomyomatosis 1 Insulinoma 1 Glucagonoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gastrinoma 1 Diarrhea 1 Chylous Ascites 1 Chylothorax 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Ascites 1 Adenoma, Islet Cell 1

Interventions

Gemcitabine 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 Cisplatin 2 selpercatinib 1 pralsetinib 1 parathyroid hormone-related peptide (1-36) 1 napabucasin 1 Thalidomide 1 Melphalan 1 Irinotecan 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Bortezomib 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡